 |
市場調查報告書
商品編碼
2091182
藥物發現質譜市場規模、佔有率和成長分析：按系統技術、管線應用、終端用戶細分市場和地區分類－2026-2033年產業預測Drug Discovery Mass Spectrometry Market Size, Share, and Growth Analysis, By System Technology, By Pipeline Application Focus, By End-User Segment, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球藥物發現質譜市場價值為 10.5 億美元，預計到 2025 年將成長至 11.4 億美元，到 2033 年將成長至 21.9 億美元，在預測期（2026-2033 年）內複合年成長率為 8.5%。
全球藥物發現質譜市場的發展主要受化合物分析需求成長的驅動，化合物分析對於提升藥物研發效率至關重要。該市場涵蓋多種儀器、耗材和軟體，能夠對小分子、代謝物和生物製藥進行鑑定、定量和表徵。質譜的高靈敏度和結構資訊顯著縮短了候選化合物的篩選時間，並降低了研發失敗率。人工智慧驅動的自動化技術正在改變市場格局，簡化資料收集、處理和解讀流程，進而提高代謝物分析和標靶檢驗的效率。隨著製藥公司將數位轉型列為優先事項，將人工智慧工具整合到分析工作流程中，能夠促進科學家之間的協作，並加快決策速度。最終，這將推動各地區對高通量質譜解決方案的需求成長和投資增加。
全球藥物發現質譜市場促進因素
在製藥業，人們越來越重視加速活性化合物的藥物發現過程，這導致對能夠提供快速篩檢結果的質譜技術的需求顯著成長。這種轉變使研究人員能夠有效率地評估大規模的化合物庫，最終縮短研發週期並最大限度地減少資源消耗。因此，各機構正在將資源投入到能夠提供高通量和卓越靈敏度的先進質譜平台。這一趨勢正在形成一個競爭激烈的市場格局，速度和效率對於製藥公司尋求的分析解決方案至關重要，從而推動了質譜技術的進一步發展和投資。
全球藥物發現質譜市場的限制因素
購置先進質譜儀的高成本對許多研究機構和小規模生技公司構成了重大挑戰。這些精密的系統需要大量的初始投資，不僅包括儀器本身，還包括離子源、檢測器和配套軟體等關鍵組件。許多機構面臨資金限制，被迫選擇其他分析方法或延後投資。這阻礙了質譜技術在藥物研發過程中的廣泛應用。因此，這些資本密集技術所帶來的經濟挑戰限制了整體市場成長。
藥物發現質譜市場的全球趨勢
全球藥物研發質譜市場正呈現出顯著的趨勢，即整合先進的離子移動率分析技術以提升複雜生物混合物的分離與分析能力。這種創新方法使研究人員能夠即時區分同量異位素，最終提高藥物研發效率。離子移動率率質譜不僅能夠更快、更可靠地鑑定代謝物並進行天然產物的高通量篩檢，從而縮短研發週期，還能最大限度地減少大規模離線處理的需求。這項進步使該技術成為製藥公司不可或缺的工具，加深了我們對蛋白質-配體相互作用的理解，並顯著提升了藥物研發專案的效率。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
全球藥物發現質譜市場規模：依系統技術分類
- 液相層析法聯用
- 氣相層析法和質譜
- 基質輔助雷射脫附游離飛行質譜法
全球藥物發現質譜市場規模：依研發管線和應用領域分類
- 目標識別與檢驗
- 先導藥物最適化與命中篩檢
- 高通量篩檢工作流程
- 藥物動力學（ADME）分析
全球藥物發現質譜市場規模：依最終用戶細分市場分類
- 製藥公司
- 生技公司
- 受託研究機構
全球藥物發現質譜市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Thermo Fisher Scientific
- Danaher Corporation
- Agilent Technologies
- Waters Corporation
- Bruker Corporation
- Shimadzu Corporation
- PerkinElmer
- Jeol Ltd
- Hitachi
- Tosoh Corporation
- Bio-Rad Laboratories
- Merck KGaA
- Qiagen
- F. Hoffmann-La Roche
- Abbott Laboratories
- Becton Dickinson
- Sysmex Corporation
- Horiba
- Rigaku Corporation
- Oxford Instruments
結論與建議
Global Drug Discovery Mass Spectrometry Market size was valued at USD 1.05 Billion in 2024 and is poised to grow from USD 1.14 Billion in 2025 to USD 2.19 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).
The Global Drug Discovery Mass Spectrometry market is propelled by the increasing demand for compound profiling essential for enhancing pharmaceutical research and development. This market encompasses a range of instruments, consumables, and software facilitating the identification, quantification, and characterization of small molecules, metabolites, and biologics. The sensitivity and structural insight offered by mass spectrometry significantly reduce time-to-candidate and attrition rates. The rise of AI-driven automation is transforming the landscape by streamlining data acquisition, processing, and interpretation, thereby enhancing efficiency in metabolite profiling and target validation. As pharmaceutical companies prioritize digital transformation, integrating AI tools into analytical workflows fosters collaboration among scientists and accelerates decision-making, ultimately driving growth and expanding investment in high-throughput mass spectrometry solutions across various regions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Mass Spectrometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Discovery Mass Spectrometry Market Segments Analysis
Global drug discovery mass spectrometry market is segmented by system technology, pipeline application focus, end-user segment and region. Based on system technology, the market is segmented into Liquid Chromatography Mass Spectrometry, Gas Chromatography Mass Spectrometry and Matrix-Assisted Laser Desorption Ionization Time-of-Flight. Based on pipeline application focus, the market is segmented into Target Identification Validation, Lead Optimization Hit Screening, High Throughput Screening Workflows and Pharmacokinetics ADME Profiling. Based on end-user segment, the market is segmented into Pharmaceutical Corporations, Biotechnology Enterprises and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Drug Discovery Mass Spectrometry Market
The increasing focus of the pharmaceutical industry on expediting the discovery of active compounds has significantly boosted the demand for mass spectrometry techniques that provide rapid screening results. This transition allows researchers to assess larger libraries of compounds in a more efficient manner, ultimately shortening development timelines and minimizing resource usage. Consequently, organizations are allocating resources to advanced mass spectrometry platforms that deliver high throughput and exceptional sensitivity. This trend has created a competitive market landscape where speed and efficiency are paramount considerations for analytical solutions sought by pharmaceutical companies, driving further advancements and investments in mass spectrometry technology.
Restraints in the Global Drug Discovery Mass Spectrometry Market
The high acquisition cost of advanced mass spectrometry instruments poses a major challenge for numerous research institutions and smaller biotech companies. These sophisticated systems necessitate considerable initial investment, which includes not only the instrument but also essential components like ion sources, detectors, and accompanying software. Many organizations face financial limitations that force them to choose other analytical methods or delay their investments, hindering the widespread implementation of mass spectrometry within the drug discovery process. As a result, the overall growth of the market is constrained by the economic challenges linked to such capital-intensive technologies.
Market Trends of the Global Drug Discovery Mass Spectrometry Market
The Global Drug Discovery Mass Spectrometry market is witnessing a notable trend towards the integration of advanced ion mobility techniques, which enhance the separation and analysis of complex biological mixtures. This innovative approach allows researchers to differentiate isobaric species in real-time, ultimately streamlining the drug discovery process. By enabling more rapid and reliable metabolite identification, as well as high-throughput screening of natural products, ion mobility mass spectrometry not only shortens development timelines but also minimizes the need for extensive offline processes. This advancement positions it as a crucial tool for pharmaceutical companies, facilitating a deeper understanding of protein-ligand interactions and driving forward the efficiency of discovery programs.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Drug Discovery Mass Spectrometry Market Size by System Technology & CAGR (2026-2033)
- Market Overview
- Liquid Chromatography Mass Spectrometry
- Gas Chromatography Mass Spectrometry
- Matrix-Assisted Laser Desorption Ionization Time-of-Flight
Global Drug Discovery Mass Spectrometry Market Size by Pipeline Application Focus & CAGR (2026-2033)
- Market Overview
- Target Identification Validation
- Lead Optimization Hit Screening
- High Throughput Screening Workflows
- Pharmacokinetics ADME Profiling
Global Drug Discovery Mass Spectrometry Market Size by End-User Segment & CAGR (2026-2033)
- Market Overview
- Pharmaceutical Corporations
- Biotechnology Enterprises
- Contract Research Organizations
Global Drug Discovery Mass Spectrometry Market Size & CAGR (2026-2033)
- North America (System Technology, Pipeline Application Focus, End-User Segment)
- US
- Canada
- Europe (System Technology, Pipeline Application Focus, End-User Segment)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (System Technology, Pipeline Application Focus, End-User Segment)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (System Technology, Pipeline Application Focus, End-User Segment)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (System Technology, Pipeline Application Focus, End-User Segment)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Waters Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bruker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jeol Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tosoh Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton Dickinson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Horiba
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rigaku Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Instruments
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
本地活動發現市場預測（2034 年）－按平台類型、設備類型、技術、應用、最終用戶和地區分類的全球分析
藥物研發市場：2026-2032年全球市場預測（依產品、藥物模式、治療領域及最終用戶分類）
全球創傷性腦損傷治療產品線分析（2026 年）（第二季洞察與臨床試驗）2026年人工智慧驅動藥物發現領域五大成長機會
藥物發現平台市場規模、佔有率和趨勢分析報告：按藥物類型、應用、治療領域、最終用途、地區和細分市場預測（2026-2033 年）心臟病學領域人工智慧市場規模、佔有率和趨勢分析報告：按組件、應用、疾病、地區和細分市場分類（2026-2033 年）
碎片分析市場：按技術、產品/服務、碎片類型和應用分類藥物發現平台市場：按藥物類型、技術、治療領域、應用、最終用戶和地區分類。囊泡轉運蛋白檢測市場：2026-2032年全球市場預測（依技術平台、產品形式、最終用戶、應用及轉運蛋白類別分類）AI驅動的藥物發現市場預測至2034年：按組件、治療領域、技術、應用、最終用戶和地區進行全球分析。